Related Experiment Video
Updated: Apr 27, 2026

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
Published on: January 19, 2024
Cutaneous adverse reactions to lenalidomide
S Imbesi1, A Allegra2, G Calapai3
1Department of Clinical and Experimental Medicine, School and Unit of Allergy and Clinical Immunology, University of Messina, Italy.
Abstract:
Lenalidomide is an immunomodulatory drug (IMiD) used principally in the treatment of multiple myeloma (MM), myelodysplastic syndromes (MS) and amyloidosis. Adverse reactions related to lenalidomide include myelosuppression (mainly neutropenia but also thrombocytopenia), gastrointestinal problems, skin eruption, atrial fibrillation and asthenia, decreased peripheral blood stem cell yield during stem cell collection, venous thromboembolism, and secondary malignances. In this review we focused our attention on the cutaneous adverse reactions to lenalidomide.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drug toxicity: Idiosyncratic Reactions
Allergic Drug Reactions
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

